Found: 16
Select item for more details and to access through your institution.
CD98 regulates the phosphorylation of HER2 and a bispecific anti‐HER2/CD98 antibody inhibits the growth signal of human breast cancer cells.
- Published in:
- Genes to Cells, 2023, v. 28, n. 5, p. 374, doi. 10.1111/gtc.13016
- By:
- Publication type:
- Article
Anti-Tumor Effect against Human Cancer Xenografts by a Fully Human Monoclonal Antibody to a Variant 8-Epitope of CD44R1 Expressed on Cancer Stem Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029728
- By:
- Publication type:
- Article
Endothelial-Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2019, v. 61, n. 3, p. 367, doi. 10.1165/rcmb.2018-0231OC
- By:
- Publication type:
- Article
Dual‐targeting therapy against HER3/MET in human colorectal cancers.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 8, p. 9684, doi. 10.1002/cam4.5673
- By:
- Publication type:
- Article
Author Correction: CD44 variant inhibits insulin secretion in pancreatic β cells by attenuating LAT1-mediated amino acid uptake.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Transcription factor Tlx1 marks a subset of lymphoid tissue organizer-like mesenchymal progenitor cells in the neonatal spleen.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-56984-w
- By:
- Publication type:
- Article
The orphan G protein–coupled receptor 141 expressed in myeloid cells functions as an inflammation suppressor.
- Published in:
- Journal of Leukocyte Biology, 2024, v. 115, n. 5, p. 935, doi. 10.1093/jleuko/qiae009
- By:
- Publication type:
- Article
MEK inhibition suppresses metastatic progression of KRAS‐mutated gastric cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 916, doi. 10.1111/cas.15244
- By:
- Publication type:
- Article
Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene.
- Published in:
- Cancer Science, 2021, v. 112, n. 2, p. 563, doi. 10.1111/cas.14741
- By:
- Publication type:
- Article
Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT‐targeted therapy.
- Published in:
- Cancer Science, 2020, v. 111, n. 1, p. 127, doi. 10.1111/cas.14224
- By:
- Publication type:
- Article
Glutaminolysis‐related genes determine sensitivity to xCT‐targeted therapy in head and neck squamous cell carcinoma.
- Published in:
- Cancer Science, 2019, v. 110, n. 11, p. 3453, doi. 10.1111/cas.14182
- By:
- Publication type:
- Article
Sulfasalazine could modulate the CD44v9‐xCT system and enhance cisplatin‐induced cytotoxic effects in metastatic bladder cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 4, p. 1431, doi. 10.1111/cas.13960
- By:
- Publication type:
- Article
Anti‐tumor effects of mAb against l‐type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes.
- Published in:
- Cancer Science, 2019, v. 110, n. 2, p. 674, doi. 10.1111/cas.13908
- By:
- Publication type:
- Article
Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B‐containing N‐methyl‐d‐aspartate–sensitive glutamate receptor signaling.
- Published in:
- Cancer Science, 2018, v. 109, n. 12, p. 3874, doi. 10.1111/cas.13826
- By:
- Publication type:
- Article
CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.
- Published in:
- Cancer Science, 2016, v. 107, n. 7, p. 991, doi. 10.1111/cas.12967
- By:
- Publication type:
- Article
NIH3 T3 cells overexpressing CD98 heavy chain resist early G1 arrest and apoptosis induced by serum starvation.
- Published in:
- Cancer Science, 2012, v. 103, n. 8, p. 1460, doi. 10.1111/j.1349-7006.2012.02304.x
- By:
- Publication type:
- Article